How Pfizer Passed on Early GLP‑1 Research in the Late 1980s and ’90s
TL;DR Jeffrey Flier recounts involvement in one of the earliest commercial efforts to develop GLP‑1–based metabolic therapies beginning in 1988.…
Wow News on Tech and AI
TL;DR Jeffrey Flier recounts involvement in one of the earliest commercial efforts to develop GLP‑1–based metabolic therapies beginning in 1988.…
TL;DR Jeffrey Flier recounts his group's late-1980s effort to develop GLP-1–based metabolic therapies under a Pfizer–California Biotechnology alliance. Despite encouraging…